240 related articles for article (PubMed ID: 37593226)
1. Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis.
Talbo MK; Katz A; Hill L; Peters TM; Yale JF; Brazeau AS
EClinicalMedicine; 2023 Aug; 62():102119. PubMed ID: 37593226
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
Jancev M; Vissers TACM; Visseren FLJ; van Bon AC; Serné EH; DeVries JH; de Valk HW; van Sloten TT
Diabetologia; 2024 May; 67(5):798-810. PubMed ID: 38363342
[TBL] [Abstract][Full Text] [Related]
4. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
[TBL] [Abstract][Full Text] [Related]
5. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566
[TBL] [Abstract][Full Text] [Related]
6. The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes?
Elbalshy M; Boucher S; Galland B; Haszard JJ; Crocket H; Wiltshire E; Jefferies C; de Bock MI; Tomlinson P; Jones S; Wheeler BJ
J Diabetes Metab Disord; 2020 Dec; 19(2):1647-1658. PubMed ID: 33553041
[TBL] [Abstract][Full Text] [Related]
7. Fear of hypoglycemia and quality of life in young people with type 1 diabetes and their parents in the era of sensor glucose monitoring.
Glocker V; Bachmann S; Hess M; Szinnai G; Burckhardt MA
Front Endocrinol (Lausanne); 2022; 13():958671. PubMed ID: 35966066
[TBL] [Abstract][Full Text] [Related]
8. Are nocturnal hypoglycemia prevention strategies influenced by diabetes technology usage? A BETTER registry analysis.
Talbo MK; Rabasa-Lhoret R; Yale JF; Peters TM; Brazeau AS
Diabetes Res Clin Pract; 2022 Sep; 191():110080. PubMed ID: 36099973
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of fear of hypoglycaemia in adults with type 1 diabetes.
Anderbro TC; Amsberg S; Moberg E; Gonder-Frederick L; Adamson U; Lins PE; Johansson UB
Endocrinol Diabetes Metab; 2018 Apr; 1(2):e00013. PubMed ID: 30815549
[TBL] [Abstract][Full Text] [Related]
10. No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study.
Saulnier PJ; Briet C; Gand E; Chaillous L; Dubois S; Bonnet F; Leguerrier AM; Fradet G; Delcourt Crespin I; Kerlan V; Gouet D; Perlemoine C; Ducluzeau PH; Pichelin M; Wargny M; Gonder-Frederick L; Ragot S; Hadjadj S; Cariou B;
J Diabetes Complications; 2019 Aug; 33(8):554-560. PubMed ID: 31182337
[TBL] [Abstract][Full Text] [Related]
11. Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials.
Godoi A; Reis Marques I; Padrão EMH; Mahesh A; Hespanhol LC; Riceto Loyola Júnior JE; de Souza IAF; Moreira VCS; Silva CH; Miyawaki IA; Oommen C; Gomes C; Silva AC; Advani K; de Sa JR
Diabetol Metab Syndr; 2023 Sep; 15(1):190. PubMed ID: 37759290
[TBL] [Abstract][Full Text] [Related]
12. The impact of fear of hypoglycaemia on sleep in adolescents with type 1 diabetes.
Hitt TA; Hershey JA; Olivos-Stewart D; Forth E; Stuart F; Garren P; Mitchell J; Hawkes CP; Willi SM; Gettings JM
Diabet Med; 2023 May; 40(5):e15066. PubMed ID: 36786042
[TBL] [Abstract][Full Text] [Related]
13. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
Brown RE; Chu L; Norman GJ; Abitbol A
Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of educational and behavioural interventions for reducing fear of hypoglycaemia among adults with type 1 diabetes: Systematic review and meta-analyses.
Chatwin H; Broadley M; de Galan B; Bazelmans E; Speight J; Pouwer F; Nefs G
Diabet Med; 2023 May; 40(5):e15071. PubMed ID: 36807935
[TBL] [Abstract][Full Text] [Related]
15. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
17. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemia avoidance behaviour and exercise levels in active youth with type 1 diabetes.
Roberts AJ; Yi-Frazier JP; Carlin K; Taplin CE
Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00153. PubMed ID: 32704571
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
Farrar D; Tuffnell DJ; West J; West HM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey.
Liu J; Bispham J; Fan L; Poon JL; Hughes A; Mcauliffe-Fogarty A; Varnado O; Mitchell B
BMJ Open; 2020 Sep; 10(9):e038462. PubMed ID: 32895285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
